Objectives The development of simple tools to identify individuals at high risk of coronary heart disease (CHD) would enable rapid implementation of preventive measures. This study was designed to ...

Gemini normalized the inflammatory response at the cellular level in stage 3 and 4 CKD patients – – Gemini could potentially revolutionize the treatment of acute and chronic inflammatory disease – ...

The researchers found that adults with learning disabilities had lower odds of poor glycemic control, faster insulin initiation, and double the risk for all-cause and diabetes-related mortality, ...

Here's the thing: You might think Domhnall Gleeson plays the new Michael Scott in "The Paper." After all, the Irish actor, 42, plays new boss Ned Sampson in "The Office" spinoff (10 episodes now ...

What if you could build a fully functional app without ever touching a line of code? Imagine creating a tool that generates professional responses to emails, complete with AI-crafted images, all in ...

The hepatitis B vaccine seems to reduce the risk of developing diabetes, and not just by preventing the infection. The vaccine is routinely offered to infants in most countries, usually via three ...

MKDPINN is a novel approach for Remaining Useful Life (RUL) prediction, combining meta-learning, knowledge discovery, and Physics-Informed Neural Networks (PINNs). This repository contains the code ...

Cecil Merkerson III is a sports writer and editor whose bold, fan-first voice brings fresh perspective to the NFL, college football, and beyond. With a background in newsroom editing and SEO strategy, ...

Columbus City Council updated city code at the end of June to make it easier to have a pollinator garden. Still, some homeowners growing native plants are facing code violations. City officials say ...

Share on Pinterest Eating a Mediterranean diet and following a healthy lifestyle can be very effective in lowering diabetes risk. Ivan Solis/Stocksy United A Mediterranean diet, combined with calorie ...

After Eli Lilly’s phase 3 data drop for its oral GLP-1 asset orforglipron earlier this month, the Indianapolis drugmaker has unveiled the second half of the data package that will support the med’s ...

Eli Lilly is releasing new Phase 3 trial results Tuesday. Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose approximately 23 ...